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Abstract
Background—Organic anion and cation transporters (OATs, OCTs and OCTNs) mediate the
proximal tubular secretion of numerous clinically important compounds, including various
commonly prescribed pharmaceuticals. Here, we examine the ontogeny of these transporters in rat
embryonic kidney in detail, both in vivo and in two in vitro organ culture models of kidney
development, whole embryonic kidney (WEK) culture and culture of induced metanephric
mesenchyme (MM).
Methods—We used QPCR to determine expression levels of transporter genes in rat embryonic
kidneys on each day of gestation from ed13 to ed18, in induced and un-induced MM, and on each
day of one week of WEK culture. We also used uptake of fluorescein as a novel functional assay of
organic anion transporter expression in WEK and MM.
Results—The developmental induction of the various organic anion and cation transporter genes
does not occur uniformly: some genes are induced early (e.g., Oat1 and Oat3, potential early markers
of proximal tubulogenesis), and others not till kidney development is relatively advanced (e.g., Oct1,
a potential marker of terminal differentiation). We also find that the ontogeny of transporter genes
in WEK and MM is similar to that observed in vivo, indicating that these organ culture systems may
appropriately model the expression of OATs, OCTs and OCTNs.
Conclusion—We show that WEK and MM cultures may represent convenient in vitro models for
study of the developmental induction of organic anion and cation transporters. Functional organic
anion transport as measured by fluorescein uptake was evident by accumulation of the fluorescence
in the developing tubule in these organ cultures. By demonstrating the mediated uptake of fluorescein
in WEK and MM, we have established a novel in vitro functional assay of transporter function. We
find that OATs, OCTs, and OCTNs are differentially expressed during proximal tubule development.
Our findings on the renal ontogeny of organic anion and cation transporters could carry implications
both for the development of more rational therapeutics for premature infants, as well as for our
understanding of proximal tubule differentiation.
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Many organic ions are excreted from the body via secretion mediated by specific transporters
in the proximal tubule of the kidney. Such transporters are located on either the basolateral or
apical surface of the proximal tubular cell, positioned so as to potentially mediate the successive
steps of basolateral uptake and apical efflux that are required for tubular secretion. Individual
transporters are also (broadly) specific for either organic anions or organic cations.
Accordingly, four functional groups of these transporters might be distinguished, apical or
basolateral organic anion transporters (OATs), and apical or basolateral organic cation
transporters (OCTs/OCTNs). Notwithstanding these functional distinctions, OATs and OCTs/
OCTNs are in fact phylogenetically related (as evidenced by their structural homology), and
are accordingly grouped within the same gene family (slc22 [1], in turn grouped within the
Major Facilitator Superfamily [MFS] of solute carriers [2]).
These transporters are of considerable pharmacological and physiological interest, because
their substrates include numerous commonly used drugs (encompassing antibiotics, antivirals,
diuretics, non-steroidal anti-inflammatories, H2-blockers, and antihypertensives, among
others). In addition, several physiologically important endogenous compounds are also
substrates; these include urate, folate, prostaglandins, choline, and monoamine
neurotransmitters (for recent reviews, see [3-5]). Thus investigation of the ontogeny of OATs,
OCTs and OCTNs will have significant implications for our understanding of the
developmental maturation of the body's capacity to ‘handle’ many clinically important
substances.
Following the molecular cloning of the genes encoding organic anion and cation transporters
(reviewed in [3,4]), there have been several studies of the developmental changes in expression
of these genes in the early post-natal period [6-8]. By contrast, changes in gene expression
occurring during embryogenesis have not been studied in detail. We previously investigated
the embryonic expression of Oat1-3 and Oct1 in mouse [9]. We discovered that renal expression
of these genes (as determined by in situ hybridization and Northern blotting) is detectable as
early as ed14, approximately coinciding with the onset of proximal tubular differentiation. (We
also discovered, unexpectedly, that these genes manifest transient embryonic expression in a
variety of disparate tissues including brain, spinal cord, aorta, heart, lung, liver, and bone, in
addition to kidney. These observations suggest a possible role for the encoded transporters in
development, conceivably involving transport of morphogens.)
A more careful analysis not only has implications for understanding the basic biology of
proximal tubule differentiation, but may also bear on the ability of premature infants to handle
a variety of drugs. We have now performed a detailed examination of the renal ontogeny of
organic anion and cation transporters in rat. The specific genes examined were Oat1
(slc22a6; [10-13]), Oat2 (slc22a7; [14,15]), Oat3 (slc22a8; [16,17]), Oct1 (slc22a1; [18,19]),
Oct2 (slc22a2; [20,21]), OCTN1 (slc22a4; [22]), and OCTN2 (slc22a5; [23-25]). Expression
of the apical proximal tubular organic anion transporters, OAT4 (slc22a11; [26]) and RST/
URAT1 (slc22a12; [27,28]), could not be examined because the corresponding rat orthologs,
if they exist, have not yet been identified. We used QPCR to determine expression levels of
the above genes in rat embryonic kidneys on each day of gestation from ed13 to ed18,
correlating our findings with expression levels of genes encoding other markers of proximal
tubular differentiation, NaPi2 (Na+/phosphate co-transporter [29]) and SGLT1 (Na+/glucose
co-transporter [30]). We also examined the expression of organic anion and cation transporters
Sweet et al. Page 2
Kidney Int. Author manuscript; available in PMC 2010 February 22.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
in two in vitro models of kidney development, whole embryonic kidney (WEK) culture [31]
and co-culture of metanephric mesenchyme (MM) with spinal cord [32]. We determined
transporter expression in these systems both by QPCR as well as functionally, by assessment
of transport of the fluorescent compound, fluorescein, which is a specific OAT substrate
[33-35]. We found that the ontogeny of transporter genes in either in vitro model was similar
to that observed in vivo. Therefore, WEK and MM cultures may represent convenient in
vitro models for study of function as well as of expression of organic anion and cation
transporter genes.
METHODS
Culture of Whole Embryonic Kidney
Uteri from timed pregnant Sprague-Dawley rats at day 13 of gestation (day 0 of gestation being
the day of appearance of the vaginal plug) were removed and the embryos dissected free of
any surrounding membranes and tissue. Kidneys were isolated from the embryos and placed
on polycarbonate Transwell filters with no separation of males and females. The organ cultures
were maintained in DME/F12 (MediaTech, Herndon, VA) supplemented with 10% FBS up to
7 days.
Isolation and culture of metanephric mesenchyme
Embryonic kidneys, isolated as described above, were incubated in L-15 media containing
0.1% trypsin and 0.05 U/μl DNase I for 15 min 37°C (no separation of males and females).
Trypsinization was stopped by the addition of FBS (final concentration of 10%) and the
metanephric mesenchyme was dissected free of the ureteric bud using minutia pins. Pieces of
embryonic spinal cord were also dissected free of surrounding tissues and collected for use as
the heterologous inducer of the MM. Embryonic spinal cord was applied to the top of a
polycarbonate Transwell filter and isolated MM was placed in contact with the embryonic
spinal cord. Tissues were maintained in DME/F12 (MediaTech, Herndon, VA) supplemented
with 10% FBS. After 24 hr of induction the spinal cord tissue was removed and the induced
MM cultured for an additional 5 days.
Quantitative polymerase chain reaction
All RNA samples were isolated using the Absolutely RNA RT-PCR Miniprep Kit (Stratagene,
La Jolla, CA) with inclusion of the optional DNase I digestion step in the protocol. RNA
isolated from adult rat kidney was reverse transcribed and used as template for standard curve
reactions for each primer pair. Standard curve values were obtained for 0.01 ng, 0.1 ng, 1 ng,
and 10 ng dilutions of the original amount of RNA that was reverse transcribed. No-template
control reactions for each primer pair were incorporated into each QPCR run. Primer pair
sequences used for QPCR analysis are listed in Table 1, final concentration in QPCR reactions
was 50 nM. Reactions were set up in 96 well plates using SYBR Green PCR Master Mix
(Applied Biosystems, Foster City, CA) according to manufacturer's specifications and samples
were run on an ABI Prism 7700 sequence detection system at the UCSD QPCR core facility.
Cycle parameters were as follows: initial 95°C denaturation step for 10 min followed by 40
cycles of 95°C denature for 20 s, 60°C anneal for 20 s, and 72°C extension for 45 s. The data
were analyzed using Sequence Detector v1.7 software. Data were normalized to the level of
expression of GAPDH in the same sample, and are reported as the ratio of the level of
normalized gene expression in the sample of interest to the level of gene expression in adult
kidney (mean value ± SD; embryonic kidney and MM were triplicate samples; cultured kidney,
duplicate samples).
Sample tissues were obtained as follows: Embryonic kidneys: renal masses were directly
dissected from ed13 through ed18 fetal rats and pooled for RNA isolation; Cultured kidneys:
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renal masses were dissected from ed13 fetal rats, cultured on Transwell support membranes
for 1 to 7 days (as described above in embryonic kidney culture), and RNA isolated from pooled
tissue; Induced metanephric mesenchyme: pooled MM tissue isolated from 13-16 ed13 rat
fetuses was co-cultured with ed13 spinal cord for 24 hr and then cultured for an additional 5
days after the removal of the spinal cord tissue (as described above in metanephric mesenchyme
culture), RNA from the induced MM was then isolated from pooled tissue.
Each RNA sample was reverse transcribed using oligo-dT and Moloney Murine Leukemia
Virus Reverse Transcriptase (Promega Corporation, Madison, WI) in reactions containing 2
μg of RNA per 25 μl of reaction volume. Each QPCR reaction contained 1 μl of RT reaction
as template with the exception of the ed18 kidney samples for which the template was diluted
10 fold. Standard curves and all samples to be compared (e.g., ed13 through ed18 or kidney
cultured for 1 day through 7 days) were analyzed on the same QPCR plate. With the exception
of β-actin in all systems, and Oat2, Oct1, and NaPi2 in the induced MM cultures, the expression
of each gene was determined in samples prepared from two independent experiments (i.e., run
1 and run 2).
Fluorescein uptake assays
Embryonic day 13 kidneys cultured for 7 days or induced MM cultured for 6 days were exposed
to 2 μM fluorescein (FL) in the culture medium (with phenol red, antibiotics, and serum
omitted) for 30 min in the absence or presence of 2 mM probenecid. Following the uptake
period, the organ cultures were washed twice with ice-cold phosphate-buffered saline prior to
examination by confocal fluorescence microscopy. Prior to confocal microscopy of
experimental groups, control tissues (no exposure to FL) were examined and microscope levels
set such that no background fluorescence was detectable.
RESULTS
Transporter expression during embryonic kidney development
The expression profiles of 10 genes (Oat1, Oat2, Oat3, Oct1, Oct2, OCTN1, OCTN2, SGLT1,
NaPi2, and β-actin) during rat embryonic kidney development from ed13 through ed18 were
examined by QPCR. Standard curves were generated for each gene of interest using a dilution
series of reverse transcribed adult rat kidney RNA as template. Profiles were then generated
for each gene of interest in the various tissue samples and values for their respective levels of
expression extrapolated from the standard curves (Fig. 1). The level of expression of each gene
of interest was then normalized to the level of expression of GAPDH in the same tissue sample
(Fig. 2).
Of all the genes examined, only Oat2 expression was never detected in embryonic kidney.
Since Oat2 message was readily detectable in newborn and adult rat kidney (not shown), its
expression is likely to be upregulated between ed18 and birth. The expression patterns of the
other genes fell into three groups: Group 1 genes manifested a generally progressive increase
between ed13 and ed18; these included the organic anion transporters Oat1 and Oat3, and the
proximal tubular markers SGLT1 and NaPi2. Group 2 genes manifested by and large similar
expression over the course of embryonic development. These genes included the organic cation
transporter, Oct2, and the organic cation/carnitine transporters, OCTN1 and OCTN2, and, as
expected, the housekeeping gene, β-actin. Finally, Oct1 was grouped separately as Group 3
since it manifested a sharp rise in expression relatively late in kidney development, around
ed18.
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Transporter expression in the induced metanephric mesenchyme culture model
Culture of the metanephric mesenchyme (MM; the embryonic tissue which is destined to give
rise to the nephrons of the kidney) in the presence of a suitable inducer has long been used to
model nephrogenesis in vitro [31,32]. For example, following induction by embryonic spinal
cord, cultured MM forms proximal tubule-like structures. We cultured spinal cord-induced and
un-induced MM (Fig. 3; see Methods for description of culture and induction of MM), and
determined the expression of organic anion and cation transporter genes (as above, Oat1, Oat2,
Oat3, Oct1, Oct2, OCTN1, OCTN2, SGLT1, and NaPi2) and of the control gene, β-actin, in
the two culture systems (Fig. 4). The expression of all the transporter genes, with the sole
exception of OCTN2, was substantially upregulated by spinal cord induction (Group A in Fig.
4). Expression of OCTN2 was similar in the induced and un-induced cultures, as was that of
the control β-actin gene (Group B).
Organic anion transport function in the induced metanephric mesenchyme culture model
We demonstrated the presence of functional organic anion transport activity in induced MM
by observing the inhibitor-sensitive uptake of the OAT substrate fluorescein (FL), which
appears to be a specific substrate for Oat1 and Oat3 [33-35] (Fig. 5). FL uptake was completely
blocked by pre-exposing the tissue to 2 mM probenecid or 10 mM p-aminohippurate for 1 hr
prior to the addition of FL to the culture medium (data not shown). Moreover, FL accumulation
occurred in a highly specific pattern being associated only with the induced tubule-like
structures (Fig. 5B). Observation at higher magnification revealed that the induced tubule-like
structures appeared to consist of a single layer of cells arranged around a central fluid-filled
space or lumen (Fig. 5C & E). In correlation with this interpretation, FL was observed to be
concentrated within this space (Fig. 5D & F).
Transporter expression in the cultured kidney model
Culture of the whole embryonic kidney (derived from ed13 rat embryos) is a second in vitro
system that is commonly used to model kidney development (Fig. 6). We used QPCR to assess
expression of Oat1, Oat2, Oat3, Oct1, Oct2, OCTN1, OCTN2, SGLT1, NaPi2, and β-actin in
WEK cultures (Fig. 7). Two major patterns of gene expression could be discriminated: Oat1,
Oat3, Oct1, SGLT1, and NaPi2 manifested a progressive increase in expression over the seven
days of WEK culture (Group A), while Oct2, OCTN1, OCTN2, and β-actin expression did not
substantially change over the duration of culture (Group B). Oat2, which was not detected in
embryonic kidneys in vivo (Fig. 2), was also undetectable in WEK culture.
Organic anion transport function in the cultured kidney model
As with induced MM culture, we established the presence of organic anion transport in WEK
(cultured for one week) by demonstrating accumulation of FL in convoluted tubule-like
structures within the organ culture (Fig. 8B, arrows). These structures appeared to be
continuous with a more deeply situated network of broader and straighter passages, presumably
part of the collecting duct system (Fig. 8B, arrowheads). As observed with MM, accumulation
of FL in WEK was completely inhibited by pretreatment with probenecid or p-aminohippurate
(data not shown).
DISCUSSION
We have closely examined the ontogeny of organic anion and cation transporter expression
during rat embryonic kidney development in vivo, using the highly sensitive method of QPCR.
We find that Oat1 and Oat3, the principal basolateral organic anion transporters of the proximal
tubule [11-13,16,17,36], as well as the proximal tubular markers, SGLT1 and NaPi2 [29,30],
manifest a progressive increase in gene expression over the period examined, ed13-18 (Fig.
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2). Thus these genes might be considered relatively early markers of nephrogenesis (provided
a sufficiently sensitive method of detection is employed). Of note, Oat1 and Oat3 are
chromosomally paired and have similar expression patterns in adult tissue [1,37]. Therefore,
their approximately cotemporal activation of expression during embryonic kidney
development may represent an instance of coordinate transcriptional regulation of linked genes.
In contrast to the basolateral OATs, expression of the basolateral organic cation transporter,
Oct1 [38,39], is undetectable till kidney development is fairly advanced, and therefore appears
to be a marker of terminal differentiation. Oct2, the other basolateral organic cation transporter
[38,39], and OCTN1 & OCTN2, apically located organic cation and carnitine transporters
[40,41], do not manifest substantial changes in expression level over the period of embryonic
development studied. Finally, Oat2 message, while expressed in adult rat and mouse kidney,
was undetectable at any embryonic time point examined in this study (ed13 through ed18).
These findings are consistent with a recent study examining OAT mRNA expression levels in
rat kidney starting at birth, in which no appreciable expression of renal Oat2 mRNA was
observed as late as 35 days of age [6].
Just as the prior studies of transporter expression in the neonatal period [6-8] could have
implications for drug dosing in pediatric patients, our results could ultimately contribute to the
development of more rational therapeutics for premature infants. Moreover, identification of
individual OATs and OCTs as potential early (Oat1, Oat3) or late (Oct1) markers of proximal
tubular differentiation could have significant implications for our understanding of the
molecular mechanisms underlying this process. For example, expression of “early” genes could
be under the direct control of “master” factors that are key regulators of proximal tubulogenesis.
Indeed, analysis of the upstream regions of the Oat1 and Oat3 genes has revealed the presence
of evolutionarily conserved binding sites for several transcription factors of demonstrated
importance to kidney development, including PAX1, WT1, and HNF1, among others [37]. Of
these factors, HNF1 seems particularly likely to be significantly involved in the maturation of
the proximal tubule; it has been shown to induce the transcription of several proximal tubular
transporters (including, of the ones examined in this study, SGLT1) [42-44], and its knockout
results in a renal Fanconi syndrome with urinary loss of glucose, amino-acids, and phosphates
[45].
We have also examined transporter expression and function in two prominent in vitro models
of nephrogenesis: whole embryonic kidney (WEK) culture, and culture of induced metanephric
mesenchyme (MM). The “organs” in these model systems grow and apparently differentiate
during culture, with formation of tubules that bear a remarkable functional as well as structural
resemblance to developing nephrons in vivo [31,32]. We now find that expression patterns of
OATs, OCTs, and OCTNs in these organ cultures also closely resemble those observed in
vivo.
In the MM model, we find that all of the genes whose expression increases at some point during
in vivo nephrogenesis (i.e., Oat1, Oat3, and OCT1) are also up-regulated in induced MM (Figs.
2 & 4). However, there is not an exact correspondence between induced MM and in vivo
development, since the gene expression of Oct2 and OCTN1 appears to be upregulated in
induced MM, but these genes do not manifest a clear trend toward increasing expression in
vivo. A unique feature of the induced MM model is the striking upregulation of Oat2
expression; the only gene examined whose expression was undetectable at any time in either
embryonic kidney or WEK culture. The WEK model recapitulates organic anion and cation
transporter gene expression patterns to an even closer degree (Figs. 2 & 7): all the genes whose
expression increases during in vivo nephrogenesis, but none of the genes whose expression
does not, manifest increasing expression over the course of WEK culture.
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Therefore, our results demonstrate that WEK and MM culture may represent convenient in
vitro models for study of the developmental induction of organic anion and cation transporter
gene expression. In addition, our results demonstrate mediated transport of the OAT-substrate
fluorescein in these models. This latter finding suggests that the transporter genes expressed
during embryonic development are, at least in some instances, functional. It also establishes
an assay for investigation of the maturation of transporter function, as well as, potentially, for
analysis of more general aspects of transporter function. In this regard, there are two important
advantages of these in vitro organ culture systems that bear mentioning. First, in each system
there appears to be an open lumen in which substrate accumulates, suggesting that these
systems may be used to study not just basolateral uptake, but the luminal efflux step of renal
solute transport as well. Second, all aspects of gene expression are under endogenous promoter
control and, thus, may more accurately reflect the in vivo pathways of gene regulation and
expression and in vivo transporter protein levels.
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Figure 1. Representative QPCR dissociation curves
Dissociation curves for Oat1, Oct2, and GAPDH from one run of the induced MM analysis
are shown and indicate the formation of a single specific PCR product for each primer pair.
Dissociation curves for all primer pairs used in this study were similar to those shown. Also
note that for Oat1, a gene for which the mRNA level was observed to change by 3-4 orders of
magnitude after induction, there is a marked change in the PCR product peak areas. In contrast,
the change in PCR product peak areas before and after induction for Oct2, a gene for which
the mRNA level was observed to change by approximately 1 order of magnitude, is not as
great.
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Figure 2. Relative gene expression levels of organic anion and cation transporter genes in embryonic
kidney as determined by QPCR
RNA was prepared from embryonic kidneys at the indicated days of gestation, reverse-
transcribed, and analyzed by QPCR (please refer to Methods for details). With the exception
of β-actin, the expression of each gene at each time point was determined in samples prepared
from two independent experiments (i.e., run 1 and run 2) and each sample was analyzed in
triplicate. Data were normalized to the level of expression of GAPDH in the same sample, and
are reported as the ratio of the level of normalized gene expression in the sample of interest to
the level of gene expression in adult kidney.
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Figure 3. Transmitted light micrographs of induced metanephric mesenchyme
Twenty-four hours of co-culture of ed13 metanephric mesenchyme with ed13 spinal cord
induces the subsequent formation of renal proximal tubule-like structures. Panel A: Rat ed13
MM tissue on Transwell filter membrane after 24 hr of co-culture (spinal cord tissue has been
removed). Panel B: Induced proximal tubule-like structures 5 days after spinal cord-induction.
Panels C and D: Higher magnification images of the regions indicated by dashed rectangles in
panel B.
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Figure 4. Relative gene expression levels of the indicated transporter genes in induced and un-
induced metanephric mesenchyme as determined by QPCR
RNA was prepared from cultures of induced and un-induced metanephric mesenchyme (please
refer to Methods for details), and QPCR analysis was performed as described in the legend for
Fig. 2. Gene expression of the examined transporter genes could be divided into two general
groups, those substantially upregulated by spinal cord induction (Group A) and those
essentially unchanged between the induced and un-induced cultures (Group B).
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Figure 5. Confocal microscopic images showing fluorescein accumulation in induced metanephric
mesenchyme
(A-L) Metanephric mesenchyme tissue isolated from ed13 rat kidneys was co-cultured with
ed13 spinal cord tissue for 24 hr and then cultured for an additional 5 days following removal
of the spinal cord tissue (please refer to Methods for details). Confocal microscopic images
were acquired 30 minutes after exposure to 2 μM fluorescein in the culture medium in either
the absence (Control; A-I) or presence (Probenecid; J-L) of 2 mM probenecid. (A, D, G, J)
Phase contrast photomicrographs of the induced epithelial tubular structures. (B, E, H, K)
Corresponding fluorescence photomicrograph of the same tissue shown in previous panel. (C,
F, I, L) Merged image of the two previous photomicrographs indicating the accumulation of
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fluorescein in the induced metanephric mesenchyme. (A-C) Low magnification examination
of a group of tubular structures in the induced mesenchyme in the absence of probenecid; Bar
= 100 μM. (D-F) High magnification examination of tubular structures in the induced
mesenchyme in the absence of probenecid; Bar = 20 μM. (G-I) Higher magnification
examination of a tubular structure in the induced mesenchyme in the absence of probenecid;
Bar = 20 μM. Note the accumulation of fluorescein, to a concentration greater than the medium,
in what appears to be a fluid filled space (presumptive lumen). (J-L) Low magnification
examination of a group of tubular structures in the induced mesenchyme in the presence of 2
mM probenecid; Bar = 100 μM. Note the absence of concentrative fluorescein accumulation.
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Figure 6. Dark-field images of whole embryonic kidney (WEK)
Culture of ed13 renal masses on transwell filter inserts for several days leads to the formation
of small organ-like structures that resemble kidneys. The micrograph depicting WEK at one
day of culture is at twice the magnification of the other micrographs.
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Figure 7. Relative gene expression levels of the indicated transporter genes in whole embryonic
kidney culture as determined by QPCR
RNA was prepared from cultures of whole embryonic kidney (please refer to Methods for
details) and QPCR analysis performed as described in the legend for Fig. 2, with the exception
that each sample was analyzed in duplicate. Two major patterns of gene expression could be
discriminated: Oat1, Oat3, Oct1, SGLT1, and NaPi2 manifested a progressive increase in
expression over the seven days of WEK culture (Group A), while Oct2, OCTN1, OCTN2, and
β-actin expression did not substantially change over the duration of culture (Group B). Oat2,
which was not detected in embryonic kidneys in vivo, was also undetectable in WEK culture.
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Figure 8. Confocal images showing fluorescein accumulation in cultured rat kidney
Embryonic day 13 kidneys isolated from rat embryos and maintained in organ culture for 7
days. Confocal images were acquired 30 minutes after exposure to 2 μM fluorescein in the
culture medium in either the absence (Control; A-I) or presence (Probenecid; J-L) of 2 mM
probenecid. (A, D, G, J) Phase contrast photomicrographs of the cultured kidneys showing the
tissue structure. (B, E, H, K) Corresponding fluorescence photomicrograph of the same tissue
shown in previous panel. (C, F, I, L) Merged image of the two previous photomicrographs
indicating the accumulation of fluorescein in the cultured kidney. Note that the fluorescein
concentration exceeds the medium concentration in specific compartments of the renal tissue.
There is an intense fluorescent signal within underlying convoluted tubule-like structures
(presumptive proximal tubules) near the surface of the organ, and a less intense signal present
in larger, straighter branching structures (presumptive collecting ducts connected to the rest of
the nephron) situated more deeply. (A-F) Low magnification examination of kidneys cultured
in the absence of probenecid; Bar = 200 μM. (G-I) High magnification examination of
collecting ducts found in kidneys cultured in the absence of probenecid. Basolateral surface of
collecting duct is indicated by dashed white line; Bar = 20 μM. (J-L) Low magnification
examination of a kidney cultured in the presence of 2 mM probenecid; Bar = 200 μM.
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Table 1
Oligonucleotide primer pairs used for QPCR analysis.
Oat1for: 5′-ATGCCTATCCACACCCGTGC-3′
Oat1rev: 5′-GGCAAAGCTAGTGGCAAACC-3′
Oat2for: 5′-TAGCTCCTGCCTCCGATTTG-3′
Oat2rev: 5′-ACCACGGCTCCCACCAGCAC-3′
Oat3for: 5′-TGAGAAGTGTCTCCGCTTCG-3′
Oat3rev: 5′-CTGTAGCCAGCGCCACTGAG-3′
Oct1for: 5′-TGGCTGGGTATACGACACTC-3′
Oct1rev: 5′-TCCTGTAGCCAGAGCCGACA-3′
Oct2for: 5′-CTGGTGCATACCGGAATCTC-3′
Oct2rev: 5′-GAACAGAGCTCGTGAACCAA-3′
OCTN1for: 5′-ACTTCGAACCCTGCCTCGGAG-3′
OCTN1rev: 5′-CTTCTCTGTCCATGGAGACTG-3′
OCTN2for: 5′-CCATATCAGTGGGCTACTTCG-3′
OCTN2rev: 5′-CCCTGAGCATCTGGTCAATGG-3′
SGLT1for: 5′-TATACCTGGCCATTTTCATCC-3′
SGLT1rev: 5′-AAGGAGCTCATGAGGGAAGCC-3′
NaPi2for: 5′-CGACATCCATCATTGTCAGCA-3′
NaPi2rev: 5′-TTTCTCCATGGTGGTGTTTGC-3′
β-actinfor: 5′-CTTCCAGCCTTCCTTCCTGGGTATGG-3′
β-actinrev: 5′-GCGGACTGTTACTGAGCTGCGTTTTA-3′
GAPDHfor: 5′-TGCACCACCAACTGCTTAGC-3′
GAPDHrev: 5′-TGGATGCAGGGATGATGTTC-3′
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